全文获取类型
收费全文 | 12274篇 |
免费 | 94篇 |
国内免费 | 29篇 |
专业分类
耳鼻咽喉 | 59篇 |
儿科学 | 1220篇 |
妇产科学 | 378篇 |
基础医学 | 1070篇 |
口腔科学 | 375篇 |
临床医学 | 574篇 |
内科学 | 2993篇 |
皮肤病学 | 381篇 |
神经病学 | 563篇 |
特种医学 | 303篇 |
外科学 | 2771篇 |
综合类 | 219篇 |
预防医学 | 395篇 |
眼科学 | 305篇 |
药学 | 381篇 |
1篇 | |
中国医学 | 92篇 |
肿瘤学 | 317篇 |
出版年
2023年 | 57篇 |
2022年 | 85篇 |
2021年 | 238篇 |
2020年 | 89篇 |
2019年 | 1610篇 |
2018年 | 1266篇 |
2017年 | 662篇 |
2016年 | 50篇 |
2015年 | 75篇 |
2014年 | 148篇 |
2013年 | 102篇 |
2012年 | 64篇 |
2011年 | 129篇 |
2010年 | 82篇 |
2009年 | 101篇 |
2008年 | 79篇 |
2007年 | 85篇 |
2006年 | 87篇 |
2005年 | 81篇 |
2004年 | 74篇 |
2003年 | 72篇 |
2002年 | 58篇 |
2001年 | 53篇 |
2000年 | 49篇 |
1999年 | 52篇 |
1998年 | 31篇 |
1997年 | 30篇 |
1996年 | 18篇 |
1995年 | 21篇 |
1994年 | 26篇 |
1993年 | 15篇 |
1992年 | 13篇 |
1991年 | 9篇 |
1990年 | 9篇 |
1989年 | 6篇 |
1986年 | 11篇 |
1985年 | 536篇 |
1984年 | 829篇 |
1983年 | 458篇 |
1982年 | 682篇 |
1981年 | 587篇 |
1980年 | 482篇 |
1979年 | 573篇 |
1978年 | 464篇 |
1977年 | 430篇 |
1976年 | 504篇 |
1975年 | 430篇 |
1974年 | 380篇 |
1973年 | 387篇 |
1972年 | 5篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
Joobin Sattar Adi Kartolo Wilma M. Hopman Joshua Matthew Lakoff Tara Baetz 《Journal of Geriatric Oncology》2019,10(3):411-414
ImportanceImmunotherapy has emerged as an effective treatment option for the management of advanced cancers. The effects of these immune checkpoint inhibitors in the older patient population has not been adequately assessed.ObjectiveTo understand the impact of aging on CTLA-4 and PDL-1 inhibitors efficacy and immune-related adverse events (irAE) in the context of real-world management of advanced solid cancers.Design, Setting, and ParticipantsThis retrospective study involved all non-study patients with histologically-confirmed metastatic or inoperable solid cancers receiving immunotherapy at Kingston Health Sciences Centre. We defined ‘older patient’ as age ≥ 75. All statistical analyses were conducted under SPSS IBM for Windows version 24.0.Main Outcomes and MeasuresStudy outcomes included immunotherapy treatment response, survival, as well as number, type, and severity of irAEs.ResultsOur study (N = 78) had 29 (37%) patients age <65, 26 (33%) patients age 65–74, and 23 (30%) patients age ≥75. Melanoma, non-small cell lung cancer, and renal cell carcinoma accounted for 70%, 22%, and 8% of the study population, respectively. Distributions of ipilimumab (32%), nivolumab (33%), and pembrolizumab (35%) were similar in the study. The response rates were 28%, 27%, and 39% in the age <65, age 64–74, age ≥75 groups, respectively (P = 0.585). Kaplan-Meier curve showed a median survival of 28 months (12.28–43.9, 95% CI) and 17 months (0–36.9, 95% CI) in the age <65 and age 64–74 groups, respectively; the estimated survival probability did not reach 50% in the age ≥75 group (P = 0.319). There were no statistically significant differences found in terms of irAEs, multiple irAEs, severity of grade 3 or higher, types of irAEs, and irAEs resolution status when comparing between different age groups.Conclusion and RelevanceOur results suggest that patients age ≥75 are able to gain as much benefit from immunotherapy as younger patients, without excess toxicity. Our findings suggest that single agent immunotherapy is generally well-tolerated across different age groups with no significant difference in the type, frequency or severity of irAEs. Future studies evaluating aging and combination immunotherapy are warranted. 相似文献
5.
6.
7.
8.
9.
《Annales médico-psychologiques》2019,177(7):676-680
Prost has hardly left his name in history as Dr. Blanche's predecessor in Montmartre. He is, however, the author of an original scientific work based on the anatomoclinical method. Military surgeon then civilian became doctor of medicine, founder and director of an important health house for lunatics, then merchant passementerie before returning to the practice of the art of healing, he was especially one of the first French alienists. 相似文献
10.